product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Human anti Interleukin-1 beta (Canakinumab Biosimilar)
catalog :
MCA6405
quantity :
0.2 mg
price :
607 USD
clonality :
monoclonal
host :
human
conjugate :
nonconjugated
clone name :
AbD52287ia
application :
ELISA
more info or order :
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA6405
Description :
Human anti Interleukin-1 beta (Canakinumab Biosimilar)
Specificity :
IL-1 Beta
TargetSpecies :
Human
Host :
Human
Format :
Purified
Isotypes :
IgG1
Applications :
E
ApplicationTypes :
ELISA
Clone :
AbD52287ia
Quantity :
0.2 mg
QuantityValue :
0.2
QuantityType :
mg
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
ProductForm :
Human IgG1 antibody selected from the HuCAL® phage display library and expressed in a mammalian cell line. This antibody is supplied as a liquid.
PriceGBP :
424
PriceEUR :
593
PriceUSD :
607 USD
PriceCHF :
645
PriceSEK :
6612
PriceNOK :
6820
PriceDKK :
4424
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.